Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention

To date, there is no FDA-approved chemoprevention approach for tobacco-related HNSCC. Effective chemoprevention approaches validated in sufficiently powered randomized trials are needed to reduce the incidence and improve survival. In this review, we recap the challenges encountered in past chemopre...

Descripción completa

Detalles Bibliográficos
Autores principales: Centuori, Sara M., Caulin, Carlos, Bauman, Julie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Head and Neck Cancer (JL Geiger, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122210/
https://www.ncbi.nlm.nih.gov/pubmed/33991232
http://dx.doi.org/10.1007/s11864-021-00848-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122210/
https://www.ncbi.nlm.nih.gov/pubmed/33991232
http://dx.doi.org/10.1007/s11864-021-00848-x

Ejemplares similares